A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma

NCT02794519 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This study has suspended participant recruitment.

Conditions

Asthma

Interventions

DRUG: Sirukumab
DRUG: Placebo
DRUG: Rescue medication

Sponsor

GlaxoSmithKline